Health Secretary Robert F. Kennedy Jr.'s new push to loosen federal restrictions on peptides could be a bonanza for telehealth companies, compounding pharmacies and longevity clinics looking for the next big wellness trend.
Why it matters: The heavily touted but loosely regulated proteins could fuel the kind of boom we've seen with weight-loss drugs — even though there's little evidence they work in humans.
